583 related articles for article (PubMed ID: 21549160)
1. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1(9-36)amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Diabetes Obes Metab; 2011 Jan; 13(1):26-33. PubMed ID: 21114600
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
4. GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice.
Tomas E; Stanojevic V; McManus K; Khatri A; Everill P; Bachovchin WW; Habener JF
Diabetes; 2015 Jul; 64(7):2409-19. PubMed ID: 25858562
[TBL] [Abstract][Full Text] [Related]
5. GLP-1-derived nonapeptide GLP-1(28-36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes.
Tomas E; Stanojevic V; Habener JF
Regul Pept; 2011 Apr; 167(2-3):177-84. PubMed ID: 21256872
[TBL] [Abstract][Full Text] [Related]
6. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
[TBL] [Abstract][Full Text] [Related]
7. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.
Neyrinck AM; Possemiers S; Verstraete W; De Backer F; Cani PD; Delzenne NM
J Nutr Biochem; 2012 Jan; 23(1):51-9. PubMed ID: 21411304
[TBL] [Abstract][Full Text] [Related]
8. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.
Cani PD; Neyrinck AM; Maton N; Delzenne NM
Obes Res; 2005 Jun; 13(6):1000-7. PubMed ID: 15976142
[TBL] [Abstract][Full Text] [Related]
9. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
[TBL] [Abstract][Full Text] [Related]
10. S 23521 decreases food intake and body weight gain in diet-induced obese rats.
Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R
Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223
[TBL] [Abstract][Full Text] [Related]
11. Low-carbohydrate diet disrupts the association between insulin resistance and weight gain.
Leite JO; DeOgburn R; Ratliff JC; Su R; Volek JS; McGrane MM; Dardik A; Fernandez ML
Metabolism; 2009 Aug; 58(8):1116-22. PubMed ID: 19439329
[TBL] [Abstract][Full Text] [Related]
12. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
Nuotio-Antar AM; Hachey DL; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220
[TBL] [Abstract][Full Text] [Related]
13. GLP-1-derived nonapeptide GLP-1(28-36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice.
Ip W; Shao W; Chiang YT; Jin T
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1348-58. PubMed ID: 24085036
[TBL] [Abstract][Full Text] [Related]
14. Resistance to high-fat diet in the female progeny of obese mice fed a control diet during the periconceptual, gestation, and lactation periods.
Gallou-Kabani C; Vigé A; Gross MS; Boileau C; Rabes JP; Fruchart-Najib J; Jais JP; Junien C
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1095-100. PubMed ID: 17164437
[TBL] [Abstract][Full Text] [Related]
15. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
[TBL] [Abstract][Full Text] [Related]
16. Fraxinus excelsior seed extract FraxiPure™ limits weight gains and hyperglycemia in high-fat diet-induced obese mice.
Ibarra A; Bai N; He K; Bily A; Cases J; Roller M; Sang S
Phytomedicine; 2011 Apr; 18(6):479-85. PubMed ID: 21036576
[TBL] [Abstract][Full Text] [Related]
17. Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.
Langeveld M; van den Berg SA; Bijl N; Bijland S; van Roomen CP; Houben-Weerts JH; Ottenhoff R; Houten SM; van Dijk KW; Romijn JA; Groen AK; Aerts JM; Voshol PJ
Metabolism; 2012 Jan; 61(1):99-107. PubMed ID: 21816446
[TBL] [Abstract][Full Text] [Related]
18. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.
Orellana-Gavaldà JM; Herrero L; Malandrino MI; Pañeda A; Sol Rodríguez-Peña M; Petry H; Asins G; Van Deventer S; Hegardt FG; Serra D
Hepatology; 2011 Mar; 53(3):821-32. PubMed ID: 21319201
[TBL] [Abstract][Full Text] [Related]
19. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.
Parlevliet ET; de Leeuw van Weenen JE; Romijn JA; Pijl H
Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E318-24. PubMed ID: 20530733
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological targeting of glucagon and glucagon-like peptide 1 receptors has different effects on energy state and glucose homeostasis in diet-induced obese mice.
Gu W; Lloyd DJ; Chinookswong N; Komorowski R; Sivits G; Graham M; Winters KA; Yan H; Boros LG; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2011 Jul; 338(1):70-81. PubMed ID: 21471191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
